Mal Interacts with Tumor Necrosis Factor Receptor-associated Factor (TRAF)-6 to mediate NF-κB Activation by Toll-like Receptor (TLR)-2 and TLR4
Journal of Biological Chemistry 279(36): 37227-37230
Article 2004 English
Authors
AM
Ashley Mansell
EB
Elizabeth Brint
JG
Jodee A. Gould
Abstract
1 min read
The Toll-interleukin-1 receptor domain-containing adapter Mal (MyD88 adapter-like protein) is involved in Toll-like receptor (TLR)-2 and TLR4 signal transduction. However, no studies have yet identified a function for Mal distinct from the related adapter MyD88. In this study, we have identified a putative TRAF6 interaction site in Mal but not in MyD88 and we demonstrate that Mal can be co-immunoprecipitated with TRAF6. Overexpression of MalE190A, which contains a mutation within the TRAF6-binding motif, failed to induce the expression of an NF-kappaB-dependent reporter gene, p65-mediated transactivation of gene expression, or activation of Jun N-terminal kinase or p42/p44 MAP kinase, which are induced with wild type Mal. MalE190A inhibited TLR2- and TLR4-mediated activation of NF-kappaB. These results identify a specific role for Mal in TLR-mediated signaling in regulating NF-kappaB-dependent gene transcription via its interaction with TRAF6.
Sinéad M. Miggin, Eva M. Pålsson‐McDermott, Aisling Dunne, Caroline A. Jefferies, Emmanuel Pinteaux, Kathy Banahan, Caroline Murphy, Paul N. Moynagh, Masahiro Yamamoto, Akira Shizuo, Nancy J. Rothwell, Douglas T. Golenbock, Katherine A. Fitzgerald, Luke O'neill
Discussion(0)
No comments yet. Be the first to comment.